Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Asia Pacific Diabetic Footwear Market is expected to register a CAGR of 9.7% during the forecast period (2017 ? 2023). Growing geriatric population has also contributed to the expansion of the diabetic footwear market. Countries such as Japan, India and China have the largest population count and geriatric population as well. Risk of diabetes is high among the aged population.
According to the report on World Population Ageing (2015) by the Department of Economic and Social Affairs Population Division ?Between 2015 and 2030, the number of people in the world aged 60 years or over is projected to grow by 56 percent, from 901 million to 1.4 billion, and by 2050, the global population of older persons is expected to be more than double its size in 2015, reaching nearly to 2.1 billion.
Increase in the disposable income of the consumers has encouraged people to spend more on their health. There has been a rapid increase in disposable income of consumers in the developing countries such as China and India. These countries are growing at a significant pace. The diabetic footwear market has been segmented on the basis of distribution channels, by footwears, by end-users, and by country.
Based on Distribution channels, the market is segmented into specialty platforms, online platforms, footwear stores, and others. Based on Footwears, the market is segmented into sandals, slippers, and shoes. Based on End-users, the market is segmented into Men's and Women's segment. Based on Country, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The key players operating in the diabetic footwear market are New Balance Athletics, Inc., Skechers U.S.A. Inc., Aetrex Industries, Inc., Orthofeet, Inc., DJO Asia Pacific, Inc., Drew Shoe Corporation, Wolverine Worldwide (Hush Puppies), and Dr. Zen Products, Inc.